FDA Import Refusal AEK-7064234-0/11/1 — Aurobindo Pharma USA Inc

Aurobindo Pharma USA Inc — FEI 3008460374

The FDA refused shipment AEK-7064234-0/11/1 from Aurobindo Pharma USA Inc (United States) on April 24, 2020. The refused product falls under Drugs and Biologics — RIBAVIRIN (ANTI-VIRAL). Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 24, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
62VDY12 RIBAVIRIN (ANTI-VIRAL)
Charges
179